General Information of Drug (ID: DM7TBUJ)

Drug Name
2-(4-phenoxyphenoxy)ethanamine Drug Info
Synonyms
2-(4-phenoxyphenoxy)ethanamine; CHEMBL472386; 2-(4-Phenoxyphenoxy)Ethylamine; 72490-14-3; SCHEMBL9486899; SCHEMBL4653229; CTK2H2396; DTXSID40452640; FBLANPWAVFBRNS-UHFFFAOYSA-N; 2-[(p-phenoxy)phenoxy]ethylamine; Ethanamine, 2-(4-phenoxyphenoxy)-; ZINC11945831; BDBM50246062
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
11031651
CAS Number
CAS 72490-14-3
TTD Drug ID
DM7TBUJ

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Bestatin DM8L9D4 Acute myeloid leukaemia 2A60 Approved [3]
LYS006 DMI17QR Ulcerative colitis DD71 Phase 2 [4]
Acebilustat DM19UTO Chronic blistering skin disorder ME63.3 Phase 1 [5]
DG051 DM3I0GS Myocardial infarction BA41-BA43 Discontinued in Phase 2 [6]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [7]
JNJ-10392980 DMZH0K8 Discovery agent N.A. Investigative [8]
4-(2-amino-1,3-thiazol-4-yl)phenol DMH5CAQ Discovery agent N.A. Investigative [9]
3-(Benzyloxy)Pyridin-2-Amine DM35VEI Discovery agent N.A. Investigative [7]
2-(7-(benzyloxy)-1H-indol-3-yl)ethanamine DMD2QVO Discovery agent N.A. Investigative [1]
2-[4-(2-Piperidin-1-ylethyl)phenoxy]benzothiazole DMMYJ3R Discovery agent N.A. Investigative [8]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
KH064 DMR1NYF Breast cancer 2C60-2C65 Clinical trial [10]
B-Octylglucoside DMMO75G Discovery agent N.A. Investigative [7]
Lauric Acid DM9C8KQ Discovery agent N.A. Investigative [7]
2-Propanol, Isopropanol DML5O0H Discovery agent N.A. Investigative [9]
CACOSPONGIONOLIDE DMIPJUS Discovery agent N.A. Investigative [11]
Elaidoylamide DMP8VDT Discovery agent N.A. Investigative [7]
Cacospongionolide E DM2DYAV Discovery agent N.A. Investigative [11]
N-Tridecanoic Acid DMNZ37C Discovery agent N.A. Investigative [9]
CACOSPONGIONOLIDE B DMCSXNW Discovery agent N.A. Investigative [11]
BOLINAQUINONE DMVB6UG Discovery agent N.A. Investigative [12]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Group IIA phospholipase A2 (GIIA sPLA2) TTO8QRU PA2GA_HUMAN Inhibitor [1]
Leukotriene A-4 hydrolase (LTA4H) TTXZEAJ LKHA4_HUMAN Inhibitor [2]

References

1 Discovery of multitarget inhibitors by combining molecular docking with common pharmacophore matching. J Med Chem. 2008 Dec 25;51(24):7882-8.
2 Activation and inhibition of leukotriene A4 hydrolase aminopeptidase activity by diphenyl ether and derivatives. Bioorg Med Chem Lett. 2008 Dec 15;18(24):6549-52.
3 DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res. 2011 Jan;39(Database issue):D1035-41.
4 Discovery of LYS006, a Potent and Highly Selective Inhibitor of Leukotriene A(4) Hydrolase. J Med Chem. 2021 Feb 25;64(4):1889-1903.
5 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
6 BAY x 1005 attenuates atherosclerosis in apoE/LDLR - double knockout mice. J Physiol Pharmacol. 2007 Sep;58(3):583-8.
7 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
8 Identification of a potent, selective, and orally active leukotriene a4 hydrolase inhibitor with anti-inflammatory activity. J Med Chem. 2008 Jul 24;51(14):4150-69.
9 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
10 D-Tyrosine as a chiral precusor to potent inhibitors of human nonpancreatic secretory phospholipase A2 (IIa) with antiinflammatory activity. Chembiochem. 2003 Mar 3;4(2-3):181-5.
11 A new cacospongionolide inhibitor of human secretory phospholipase A2 from the Tyrrhenian sponge Fasciospongia cavernosa and absolute configuration... J Nat Prod. 1998 Jul;61(7):931-5.
12 New sesquiterpene derivatives from the sponge Dysidea species with a selective inhibitor profile against human phospholipase A2 and other leukocyte... J Nat Prod. 2001 May;64(5):612-5.